Methyl Alcohol

Methyl Alcohol

SCHEMBL6497173

C1=Cc2cc3ccc(cc4nc(cc5ccc(cc1n2)[nH]5)C=C4)[nH]3.CO

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 1/20 0.39
▸ STAT1 P42224 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Alcohol SCHEMBL28216393 0.98 STAT3 (0.38) STAT3STAT1
Methyl Alcohol SCHEMBL27675581 0.98 STAT3 (0.38) STAT3STAT1
Methyl Alcohol SCHEMBL28910587 0.98 STAT3 (0.38) STAT3STAT1
SCHEMBL2207248 0.95 STAT3 (0.41) STAT3STAT1
Methyl Alcohol SCHEMBL2965669 0.94 STAT3 (0.36) STAT3STAT1
Methyl Alcohol SCHEMBL2965672 0.94 STAT3 (0.36) STAT3STAT1
Hydrogen Peroxide SCHEMBL28310892 0.93 STAT3 (0.43) STAT3STAT1
SCHEMBL30821407 0.93 STAT3 (0.42) STAT3STAT1
SCHEMBL29430977 0.93 STAT3 (0.42) STAT3STAT1
SCHEMBL15809 0.93 STAT3 (0.42) STAT3STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109718207-A Chemotherapeutic-photosensitizer is total to assemble nanometer grain and its building 沈阳药科大学 2019-05-07 — — CN claimed
CN-106310256-A Fabrication method and application of cellulose membrane of a drug loading breast cancer-targeting magnetic nanoparticles 华南师范大学 2017-01-11 — — CN claimed
JP-9173840-A — — None — — JP disclosed
CN-115824992-A Double-interval response pH optical probe 厦门大学 2023-03-21 — — CN disclosed
CN-107899013-B Preparation method of mesoporous manganese dioxide nano drug-loading system with photodynamic therapy switching effect and molecular recognition effect 郑州大学 2020-01-14 — — CN disclosed
CN-106668871-B A kind of preparation method and application for the Photosensitive magnetic nano particle system inhibiting breast cancer cell growth 华南师范大学 2019-08-06 — — CN disclosed
CN-110025783-A A kind of hematoporphyrin monomethyl ether/poly lactide-glycolide acid nanosphere and its preparation method and application 重庆医科大学 2019-07-19 — — CN disclosed
CN-109310702-A Nano particle for chemotherapy, targeted therapies, photodynamic therapy, immunotherapy and any combination of them 芝加哥大学 2019-02-05 — — CN disclosed
CN-109035688-A Oxygen concentration combined aural and visual alarm based on phosphorescence 山东师范大学 2018-12-18 — — CN disclosed
CN-107589073-A A kind of photosensitizer for photodynamic therapy singlet oxygen quantum yield measuring method and device 哈尔滨工业大学 2018-01-16 — — CN disclosed
CN-106551904-A The sound of target tumor, light power medicament-carried nano micelle and its production and use 天津医科大学 2017-04-05 — — CN disclosed
CN-102899028-B Metering type fluorinion fluorescence probe and preparation method UNIV HANGZHOU NORMAL 2014-06-25 — — CN disclosed
CN-102899028-A Metering type fluorinion fluorescence probe and preparation method UNIV HANGZHOU NORMAL 2013-01-30 — — CN disclosed
CN-101857597-B Diethylene triamine pentaacetic acid or ethylene diamine tetraacetic acid or amine triacetic acid modified porphyrin, preparation method and application thereof INST BIOMEDICAL ENG CAMS 2013-01-16 — — CN disclosed
CN-101857597-A Diethylene triamine pentaacetic acid or ethylene diamine tetraacetic acid or amine triacetic acid modified porphyrin, preparation method and application thereof INST BIOMEDICAL ENG CAMS 2010-10-13 — — CN disclosed
US-6849730-B2 Methods of making porphyrins and related compounds with Lewis acids NORTH CAROLINA STATE UNIVERSITY (US) 2005-02-01 — — US disclosed
CN-1504189-A PDT composition containing benzo porphyrin compound and preparation method 北京工商大学 2004-06-16 — — CN disclosed
US-20030096978-A1 Methods of making porphyrins and related compounds with Lewis acids NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2003-05-22 — — US disclosed
WO-2003027066-A2 METHODS OF MAKING PORPHYRINS AND RELATED COMPOUNDS WITH LEWIS ACID NORTH CAROLINA STATE UNIVERSITY (US) 2003-04-03 — — WO disclosed
JP-H09173840-A WATER PHOTOREDUCING ELEMENT TOKYO GAS CO LTD 1997-07-08 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096978-A1 Methods of making porphyrins and related compounds with Lewis acids DDT, LIG3, SHARPIN STAT3 3690/4885STAT1 4534/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback